Keywords: ROT; health insurance claims; ACE; Angiotensin-converting enzyme; CNS; Central nervous system; EOT; End of treatment; RR; Risk ratio;
مقالات ISI ROT (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ROT; AD; Anatomically designed; AF; Atrial fibrillation; AIC; Akaike information criteria; AOT; Actual occupancy time; CEA; Cost effectiveness analysis; DES; Discrete event simulation; DRG; Diagnostic related group; EOT; Effective occupancy time; HTA; Health t
Keywords: ROT; EOT; MIM structures; SPP; Dispersion relation; FDTD;
Keywords: ROT; Childhood asthma; Efficacy; Omalizumab; Safety evaluation; Total IgE; AEs; adverse events; ER; emergency room; EOT; end of the treatment period; ELISA; enzyme-linked immunosorbent assay; FP; fluticasone propionate; FEV1; forced expiratory volume in 1Â s;
Keywords: ROT; FLINT; NAFLD; Direct Comparison; Non-Invasive; AUROC; area under receiving operating curve; CI; confidence interval; CRN; clinical research network; EOT; end of treatment; MRI; magnetic resonance imaging; NAFLD; nonalcoholic fatty liver disease; NASH; non
Keywords: ROT; Topical Corticosteroid; Esophageal Eosinophil; Symptom Score; Clinical Trial; AE; adverse event; CSS; Clinical Symptom Score; DSQ; Dysphagia Symptom Questionnaire; EoE; eosinophilic esophagitis; EOT; end of treatment; FDA; Food and Drug Administration; GE
Keywords: ROT; EOT; Melinau; Sarawak; Larger foraminifera; Extinction; Isotopes
Keywords: ROT; ABC; ATP binding cassette; ADP; Adenosine-5â²-diphosphate; AMP; Adenosine-5â²-monophosphate; AMPPNP; Adenosine-5â²-(β,γ-imido)triphosphate; ATP; Adenosine-5â²-triphosphate; BACE1; β-Site amyloid precursor protein cleaving enzyme 1; BPM; Biophysical
Keywords: ROT; AND; Affective Network Dysfunction; DDF; difficulty describing feelings; DES; Dissociative Experiences Scale; DIF; difficulty identifying feeling; EOT; externally-oriented thinking; GSEs; general sleep experiences; ISES; Iowa Sleep Experiences Survey; MLM
Keywords: ROT; Baob; stand basal area measured over bark (m2Â haâ1); CHP; compensation heat pulse method used to measure sap velocity (Vs); dbh; stem diameter measured at 1.3 m height (cm); Ea; actual total evapotranspiration from overstorey, understorey and forest fl
One-pot synthesis of bioactive cyclopentenones from α-linolenic acid and docosahexaenoic acid
Keywords: ROT; ARA; arachidonic acid; AOC; allene oxide cyclase; AOS; allene oxide synthase; Cyp20-3; cyclophilin 20-3; DHA; docosahexaenoic acid; EDH; 16,17-epoxy-4,7,10,13,15,19-docosahexaenoic acid; EOT; 12,13-epoxy-9,11,15-octadecatrienoic acid; LeA; linolenic acid;
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Keywords: ROT; HCV; RASs; DAA; Virologic Treatment Failure; DAA; direct-acting antiviral; DCV; daclatasvir; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; NS; nonstructural protein; PCR; polymerase chain reaction; PEG IFN; pegylated interf
Charge pumping test technique using CMOS ring oscillator on leakage issue
Keywords: ROT; Charge pumping (CP); Tunneling current; EOT; MOSFET; Ring oscillator;
Original scientific articleSyndecan-1: A Quantitative Marker for the Endotheliopathy of Trauma
Keywords: ROT; ED; emergency department; EGL; endothelial glycocalyx; EoT; endotheliopathy of trauma; IQR; interquartile range; ISS; Injury Severity Score; ROC; receiver operating characteristic; sTM; soluble thrombomodulin;
The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome
Keywords: ROT; DIF; Difficulty Identifying Feelings; DDF; Difficulty Describing Feelings; EOT; Externally Oriented Thinking; FGID; Functional Gastrointestinal Disorders; GSA; Gastrointestinal-specific Anxiety; GSRS-IBS; Gastrointestinal Symptom Rating Scale-IBS; HADS; H
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Keywords: ROT; Routine Clinical Practice; Direct-Acting Antiviral Agents; Cirrhosis; Genotype 4; DAA; direct-acting antiviral agent; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; OMV; ombitasvir; PTV; paritaprevir; r; ritonavir; RBV; riba
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis
Keywords: ROT; PDCD1; Immune Regulation; Response To Treatment; Liver Disease; BAFF; B-cell-activating factor of the tumor necrosis factor family; BR3; B-lymphocyte stimulator receptor 3; CV; cryoglobulinemia vasculitis; DAA; direct-acting antiviral; EOT; end of treat
The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis
Keywords: ROT; CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease; DPI; dry powder for inhalation; EOS; end of study; EOT; end of treatment; FAS; full analysis set; FEV1; forced expiratory volume in 1Â s; FVC; forced vital capacity; MIC; minimum inhibitory
Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder
Keywords: ROT; adolescent; child; urinary incontinence; urinary bladder; overactive; solifenacin succinate; AE; adverse event; CNS; central nervous system; DBP; diastolic blood pressure; ECG; electrocardiogram; EoT; end of treatment; FAS; full analysis set; OAB; overact
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection
Keywords: ROT; Genetics; Liver Cancer; Mutation; Metalloprotease; AFP; α-fetoprotein; anti-HBc; antibody to hepatitis B core antigen; BMP1; bone morphogenetic protein 1; CCl4; carbon tetrachloride; CDAA; choline-deficient L-amino acid-defined; CHC; chronic hepatitis C;
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study
Keywords: ROT; AE; adverse events; DAAs; direct-acting antiviral agents; DCV; daclatasvir; EOT; end of treatment; GFR; glomerular filtration rate; HCV; hepatitis C virus; HIV; human immunodeficiency virus; IMS; immunosuppressive; LLOQ; lower limit of quantification; LT;
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled study
Keywords: ROT; ADV; adefovir; AEs; adverse events; ALT; alanine aminotransferase; BMI; body mass index; CHB; chronic hepatitis B; EOF; end of follow-up; EOT; end of treatment; ETV; entecavir; HBV; hepatitis B virus; HBeAg; hepatitis B e antigen; HBeAb; hepatitis B e ant
The Cenozoic history of the Armorican Massif: New insights from the deep CDB1 borehole (Rennes Basin, France)
Keywords: ROT; Eocene; Oligocene; EOT; Weathering profile; Continental drilling;
The Eocene-Oligocene climate transition in the Central Paratethys
Keywords: ROT; EOT; Paleogene; Climate evolution; δ18O and δ13C records; Paleoceanography; Foraminifera; Calcareous nannoplankton
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Keywords: ROT; HCV; hepatitis C virus; DAA; direct-acting antivirals; SVR; sustained virological response; MELD; model for end-stage liver disease; HCC; hepatocellular carcinoma; BCLC; Barcelona Clinic Liver Cancer group; LOD; limit of detection; EOT; end of treatment;
Electrical characteristics of ALD La2O3 capping layers using different lanthanum precursors in MOS devices with ALD HfO2, HfSiOx, and HfSiON gate dielectrics
Keywords: ROT; High-k; VFB shift; La2O3; Atomic layer deposition; EOT;
Gate leakage current suppression and reliability improvement for ultra-low EOT Ge MOS devices by suitable HfAlO/HfON thickness and sintering temperature
Keywords: ROT; Ge MOS; High-k; HfON; HfAlO; Sintering; EOT
Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function
Keywords: ROT; Immune Regulation; NS5A Inhibitor; NS3 Inhibitor; ISG; APC; allophycocyanin; ASV; asunaprevir; CXCL; chemokine C-X-C motif ligand; DAA; direct-acting antiviral; DCV; daclatasvir; EMA; ethidium monoazide; EOT; end of treatment; FBS; fetal bovine serum; FIT
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
Keywords: ROT; Chronic Delta Hepatitis; Pegylated Interferon Treatment; Treatment Outcome Prediction; On-Treatment HDV RNA; AD; adefovir dipivoxil; AUC; area under the curve; CDH; chronic delta hepatitis; CI; confidence interval; EOT; end of treatment; HBsAg; hepatitis
High-K materials and metal gates for CMOS applications
Keywords: ROT; ALD; atomic layer deposition; CB; conduction band; CBO; conduction band offset; CMOS; complimentary metal oxide semiconductor; CNL; charge neutrality level; CV; capacitance voltage; CVD; chemical vapour deposition; DB; dangling bond; DOS; density of state
Formation of amorphous Yb2O3/crystalline ZrTiO4 gate stack and its application in n-MOSFET with sub-nm EOT
Keywords: ROT; Orthorhombic ZrTiO4; Yb2O3; EOT; Interface trap density; Fixed oxide charge; Mobility; Reliability; BTI;
Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24 week, double-blind, randomized Phase 3 trial
Keywords: ROT; AE; adverse event; Apo; apolipoprotein; BMI; body mass index; CV; cardiovascular; CVD; cardiovascular disease; EOT; end of treatment; EZE; ezetimibe; HbA1c; glycated hemoglobin A1c; HDL-C; high-density lipoprotein cholesterol; IQR; interquartile range; IT
Research ArticlePhase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure
Keywords: ROT; PVT; portal vein thrombosis; TPO-R; thrombopoietin receptor; NASH; non-alcoholic steatohepatitis; MELD; model for end-stage liver disease; PK; pharmacokinetic; PD; pharmacodynamic; EOT; end of treatment; AE; adverse events; BMI; body mass index; CTP; Chil
Research ArticleA randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
Keywords: ROT; Lambda; peginterferon lambda-1a; alfa; peginterferon alfa-2a; GT1,4; HCV genotype 1 or 4; GT2,3; HCV genotype 2 or 3; cEVR; complete early virologic response; RVR; rapid virologic response; EOT; end-of-treatment; SVR12; sustained virologic response at pos
Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy
Keywords: ROT; ALT; Liver Cancer; Risk Factor; Response to Therapy; Outcome; AFP; α-fetoprotein; AFP24; α-fetoprotein levels at 24 weeks after the end of treatment; ALT; alanine aminotransferase; ALT24; alanine aminotransferase levels at 24 weeks after the end of trea
Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
Keywords: ROT; PROMISE; Chronic Hepatitis C; Drug; DAA; AE; adverse event; CI; confidence interval; DAA; direct-acting antiviral agent; EC50; median effective concentration; EOT; end of treatment; FDA; Food and Drug Administration; HCV; hepatitis C virus; IQR; interquar
Simeprevir Increases Rate of Sustained Virologic Response Among Treatment-Experienced Patients With HCV Genotype-1 Infection: A Phase IIb Trial
Keywords: ROT; Direct-Acting Antivirals; DAA; Clinical Trial; SVR24; AE; adverse event; EOT; end of treatment; FSS; Fatigue Severity Scale; HCV; hepatitis C virus; PegIFN; peginterferon-α2a; PegIFN-α; peginterferon-α; RBV; ribavirin; RVR; rapid virologic response; SV
Gate-last integration on planar FDSOI for low-VTp and low-EOT MOSFETs
Keywords: ROT; MOSFET; SOI; Replacement gate; EOT; Metal gate work function;
Research ArticleResponse to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
Keywords: ROT; HBeAg; hepatitis B e antigen; CHB; chronic hepatitis B; HBV; hepatitis B virus; IFN; interferon; ALT; alanine aminotransferase; HBsAg; hepatitis B s antigen; EOT; end-of-treatment; PPV; positive predictive value; LVR; long-term virological response; ROC;
Precursors as enablers of ALD technology: Contributions from University of Helsinki
Keywords: ROT; acac; acetylacetonate; ALD; atomic layer deposition; CET; capacitance equivalent thickness; CHT; cycloheptatrienyl; CHD; cyclohexadiene; CMOS; complementary metal oxide semiconductor; CN; coordination number; Cp; cyclopentadienide; COD; cyclooctadiene; CV
Safety and Tolerability of Solifenacin Add-on Therapy to α-Blocker Treated Men With Residual Urgency and Frequency
Keywords: ROT; urinary bladder; overactive; muscarinic antagonists; adrenergic alpha-antagonists; AE; adverse event; BOO; bladder outlet obstruction; BPH; benign prostatic hyperplasia; EOT; end of treatment; I-PSS; International Prostate Symptom Score; LUTS; lower urina
Two-step annealing effects on ultrathin EOT higher-k (k = 40) ALD-HfO2 gate stacks
Keywords: ROT; High-k; HfO2; ALD; Cubic; PDA; EOT
Effect of post metallization annealing on structural and electrical properties of Ge metal-oxide-semiconductor (MOS) capacitors with Pt/HfO2 gate stack
Keywords: ROT; MOS; HfO2; Metal gate; Effective work function; EOT; Fermi level pinning
Ge metal-oxide-semiconductor devices with Al2O3/Ga2O3(Gd2O3) as gate dielectric
Keywords: ROT; High-κ dielectric; Germanium; EOT; MOS
Experimental study of electron mobility characterization in direct contact La-silicate/Si structure based nMOSFETs
Keywords: ROT; Direct-contact high-k/Si structure; Rare earth oxides; Silicate; EOT; Effective mobility;
Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
Keywords: ROT; Prospective Clinical Trial; Replication Suppression; Liver Disease; ADV; adefovir dipivoxil; CHB; chronic hepatitis B; EOT; end of treatment; NUC; nucleos(t)ide analogue; OR; odds ratio; PCR; polymerase chain reaction; SR; sustained response; ULN; upper l
High-field mobility metal-gate/high-κ Ge n-MOSFETs with small equivalent-oxide-thickness
Keywords: ROT; High-κ dielectric; Ge; EOT; Mobility
Research ArticleVitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
Keywords: ROT; HCV; hepatitis C virus; SVR; sustained virologic response; RVR; rapid virologic response; EOT; end of treatment; EVR; virologic response, early virologic response; IFN; interferon; ALT; alanine aminotransferase; AST; aspartate aminotransferase; VDR; vitam
Research ArticlePredictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
Keywords: ROT; HRS; hepatorenal syndrome; MELD; model for end-stage liver disease; MAP; mean arterial pressure; SCr; serum creatinine; CI; confidence intervals; EOT; end of treatment;
Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections
Keywords: ROT; C209; VX-950; Liver Disease; Clinical Trial; AE; adverse event; EOT; end of treatment; HCV; hepatitis C virus; IL; interleukin; NS; nonstructural; Peg-IFN; peginterferon; PR; peginterferon alfa-2a (180 μg once weekly) and ribavirin (400 mg twice daily);